- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: hereditary angioedema.
Displaying page 1 of 1.
EudraCT Number: 2020-000570-25 | Sponsor Protocol Number: CSL312_3001 | Start Date*: 2021-02-09 | |||||||||||
Sponsor Name:CSL Behring LLC | |||||||||||||
Full Title: A multicenter, double-blind, randomized, placebo-controlled, parallel-arm study to investigate the efficacy and safety of subcutaneous administration of CSL312 (garadacimab) in the prophylactic tr... | |||||||||||||
Medical condition: Hereditary angioedema | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) HU (Ongoing) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000197-14 | Sponsor Protocol Number: ISIS721744-CS3 | Start Date*: 2020-06-16 | |||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc. | |||||||||||||
Full Title: An Open-Label Extension Study of ISIS 721744 in Patients with Hereditary Angioedema | |||||||||||||
Medical condition: Hereditary Angioedema | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019670-32 | Sponsor Protocol Number: B1 | Start Date*: 2013-01-31 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Pharmacokinetics and Safety of Human Pasteurised C1-Inhibitor Concentrate (Berinert/CE1145) in Subjects with Congenital C1-INH Deficiency and Frequent Hereditary Angioedema (HAE) Attacks. | |||||||||||||
Medical condition: Hereditary Angioedema (HAE) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003445-11 | Sponsor Protocol Number: PHA022121-C201 | Start Date*: 2021-01-27 | ||||||||||||||||||||||||||
Sponsor Name:Pharvaris Netherlands BV | ||||||||||||||||||||||||||||
Full Title: A Phase II, double-blind, placebo-controlled, Randomized, cross-over, dose-ranging study of oral PHA-022121 for Acute treatment of angioedema attacks in Patients with hereditary angioedema due to C... | ||||||||||||||||||||||||||||
Medical condition: Hereditary angioedema attacks caused by Type 1 and 2 C1-Inhibitor Deficiency | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: HU (Ongoing) DE (Ongoing) CZ (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003281-27 | Sponsor Protocol Number: BCX7353-204 | Start Date*: 2017-12-27 | |||||||||||
Sponsor Name:BioCryst Pharmaceuticals Inc | |||||||||||||
Full Title: An Open-Label study to Evaluate the Long-Term Safety of Daily Oral BCX7353 in subjects with Type I and II Hereditary Angioedema | |||||||||||||
Medical condition: Hereditary Angioedema | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) HU (Completed) DK (Completed) AT (Ongoing) ES (Completed) SK (Ongoing) PL (Ongoing) BE (Completed) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004489-32 | Sponsor Protocol Number: KVD900-201 | Start Date*: 2019-03-13 |
Sponsor Name:KalVista Pharmaceuticals Ltd | ||
Full Title: A randomized, double-blind, placebo-controlled, phase II, cross-over clinical trial evaluating the efficacy and safety of KVD900, an oral plasma kallikrein inhibitor, in the on-demand treatment of ... | ||
Medical condition: Hereditary Angioedema Type I or II | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) AT (Completed) HU (Completed) NL (Completed) PL (Ongoing) IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001044-22 | Sponsor Protocol Number: ISIS721744-CS2 | Start Date*: 2020-03-27 | |||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double Blind, Placebo Controlled, Phase 2a Study to Assess the Clinical Efficacy of ISIS 721744, a Second Generation Ligand Conjugated Antisense Inhibitor of Prekallikrein, in Patient... | |||||||||||||
Medical condition: Hereditary Angioedema | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004136-30 | Sponsor Protocol Number: DEALSZ-2018-001 | Start Date*: 2019-07-02 | ||||||||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin Klinik für Dermatologie und Allergologie | ||||||||||||||||||
Full Title: An Open-Label, Pilot Study to assess the effect of Lanadelumab on the clinical signs and symptoms of Hereditary angioedema with normal C1-inhibitor | ||||||||||||||||||
Medical condition: Lanadelumab in patients with Hereditary angioedema | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000605-24 | Sponsor Protocol Number: CSL312_2001 | Start Date*: 2018-12-20 | |||||||||||
Sponsor Name:CSL Behring LLC | |||||||||||||
Full Title: A multicenter, randomized, placebo-controlled, parallel-arm study to investigate the efficacy, pharmacokinetics, and safety of CSL312 in subjects with hereditary angioedema | |||||||||||||
Medical condition: Hereditary angioedema | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003966-29 | Sponsor Protocol Number: BCX7353-302 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:BioCryst Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two dose levels of BCX7353 as an oral treatment for the prevention of attacks in... | |||||||||||||
Medical condition: Hereditary angioedema | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Prematurely Ended) IE (Prematurely Ended) GB (GB - no longer in EU/EEA) FR (Ongoing) DE (Ongoing) DK (Completed) HU (Ongoing) CZ (Ongoing) AT (Ongoing) NL (Ongoing) BE (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004282-15 | Sponsor Protocol Number: C1 1304-01 | Start Date*: 2005-06-22 | |||||||||||
Sponsor Name:PHARMING TECHNOLOGIES B.V. | |||||||||||||
Full Title: A randomized, placebo-controlled, double-blind Phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema | |||||||||||||
Medical condition: hereditary angioedema (HAE) treatment | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002093-42 | Sponsor Protocol Number: SHP643-301 | Start Date*: 2020-02-04 | ||||||||||||||||
Sponsor Name:Shire (Shire is now part of Takeda) | ||||||||||||||||||
Full Title: SPRING STUDY: An Open-Label, Multicenter, Phase 3 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Lanadelumab for Prevention Against Acute Attacks of Hereditary Angioedema (... | ||||||||||||||||||
Medical condition: Hereditary Angioedema (HAE) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) HU (Ongoing) ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
